Physician

Steven V Kozmary, MD

According to 2025 Medicare claims, Steven Kozmary, MD (NPI: 1659337459) practices interventional pain management (ipm) in the Lake Havasu City-Kingman, AZ market, with the plurality of this provider's patient population coming from Mohave, AZ. This provider's primary affiliated billing organization is STEVEN V KOZMARY MD LLC (NPI: 1063579803; TIN: 88-0250024) and primary practice location at 89102-4266.

Kozmary's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 696 traditional Medicare patients, billed 13,449 HCPCS/CPT codes, and received $1,153,083 in Medicare payments. The top billing code was 64493 (Injection of lower or sacral spine facet joint using imaging guidance, single level). Part D data shows 427 prescription claims across 196 beneficiaries totaling $18,742 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). 2021 DME data shows 36 claims. Open Payments data shows 3 records totaling $145. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $519,288 to $18,742. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $16,902 to $1,409.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	797	26,465	$1,188,280
2016	807	10,188	$909,618
2017	1,321	9,889	$946,588
2018	826	16,338	$1,376,841
2019	693	14,430	$1,224,831
2020	561	11,787	$1,013,217
2021	559	11,673	$963,008
2022	959	15,765	$1,292,750
2023	861	16,304	$1,357,798
2024	696	13,449	$1,153,083

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	321	2,373	$519,288
2016	313	2,277	$394,476
2017	229	870	$335,404
2018	393	2,309	$271,563
2019	165	630	$109,818
2020	238	617	$41,126
2021	67	144	$8,227
2022	N/R	20	$5,773
2023	485	2,181	$113,859
2024	196	427	$18,742

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	72	$10,374
2016	19	66	$21,987
2017	117	130	$87,035
2018	N/R	N/R	N/R
2019	37	37	$33,939
2020	N/R	N/R	N/R
2021	36	36	$27,231
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64493	Injection of lower or sacral spine facet joint using imaging guidance, single level	63	100	$142
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	676	6,094	$112
64494	Injection of lower or sacral spine facet joint using imaging guidance, second level	47	78	$67
80307	Testing for presence of drug, by chemistry analyzers	685	6,180	$61
J1100	Injection, dexamethasone sodium phosphate, 1 mg	105	227	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	98	2,685	$3,638
Gabapentin	Gabapentin	79	3,496	$1,214
Pregabalin	Pregabalin	19	546	$669
Diclofenac Sodium	Diclofenac Sodium	16	422	$423
Oxycodone Hcl	Oxycodone Hcl	15	403	$358

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$145	Forte Bio-Pharma LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Steven V. Kozmary, MD?

Tedicare shows public-source Medicare data for Steven V. Kozmary, MD (NPI 1659337459), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Steven V. Kozmary, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Steven V. Kozmary, MD?

Steven V. Kozmary, MD is linked to STEVEN V KOZMARY MD LLC (billing NPI 1063579803) in the available physician profile data.

Does Steven V. Kozmary, MD have Open Payments data?

Steven V. Kozmary, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.